Answers are grounded in this paper and cite their sources.
Multi-center study develops predictive models for BRCA testing in Asian ovarian cancer patients, suggesting better resource use.
Background: Germline BRCA1/2 testing is recommended for all ovarian cancer patients, as identifying pathogenic variants (PVs) informs treatment and enables family cascade testing. However, in resource-limited settings, high testing costs often limit feasibility. An alternative approach is to use predictive models to prioritize patients at risk, optimizing resource allocation. Existing models are largely Western-derived; in Asian populations, models exist for breast cancer—not ovarian cancer. Methods: Using data from a multi-center study of 1,126 Asian patients with ovarian cancer (including 147 BRCA PV carriers), we developed models incorporating cancer history, clinicopathological features, and reproductive factors to estimate likelihood of carrying PVs. We assessed discrimination, calibration, and accuracy, and compared genetic testing costs to a universal testing strategy. Results: Our final model demonstrated good calibration and strong discriminatory power, with an area under the curve of 0.80 (95% confidence interval:0.74–0.87). Factors included in the model were age at diagnosis, ethnicity, personal and family cancer history, and clinicopathological features. The model had 77% accuracy at the optimal threshold for testing, compared to 13% accuracy with universal testing, reducing genetic testing costs from ~USD4,371 to ~USD1,974 per identified carrier. Notably, while maintaining 100% sensitivity, the model reduced testing by 15%, yielding potential savings of ~USD68,182 per 800 patients each year. Conclusions: Targeted testing using a prediction model potentially offers a more efficient and scalable alternative when universal testing is not feasible, optimizing impact in resource-limited settings. Impact: This work supports more affordable and equitable BRCA testing pathways for Asian ovarian cancer patients.
No takes yet. Share an insight, caveat, or question.
Ang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: